Literature DB >> 25070242

Regulatory T cells and T-cell-derived IL-10 interfere with effective anti-cytomegalovirus immune response.

Nils H Jost1, Simone Abel1, Marina Hutzler1, Tim Sparwasser2, Albert Zimmermann3, Axel Roers4, Werner Müller5, Robert Klopfleisch6, Hartmut Hengel7, Astrid M Westendorf1, Jan Buer1, Wiebke Hansen8.   

Abstract

Cytomegalovirus (CMV) establishes lifelong chronic infection in its host with mostly asymptomatic or only mild disease, but under immunosuppressive conditions the virus can reactivate and infection can cause life-threatening disease. CMV has evolved several mechanisms to escape from host's immunity, allowing persistence of the virus. Until now, it remains elusive whether regulatory T cells (Tregs) have an impact on insufficient host immune response against the virus in this context. In the present study, we provide evidence that CD4(+)Foxp3(+) naturally occurring Tregs (nTregs) as well as CD4(+)Foxp3(-)IL-10(+)-induced Tregs (iTregs) interfere with an effective anti-mouse CMV (mCMV) immune response. Depletion of Foxp3(+) Tregs by using DEREG mice resulted in enhanced T-cell activation as measured by the expression of CD62L, granzyme B and interferon (IFN)-γ and was associated with reduced viral titers in salivary glands, the organ where mCMV mainly persists. Moreover, we identified CD4(+)Foxp3(-) T cells to produce elevated levels of the immunosuppressive cytokine IL-10 at early time points during mCMV infection. Analysis of T-cell activation and viral replication in mCMV-infected IL-10(flox/flox) × CD4-cre mice and IL-10(flox/flox) × FIC mice revealed that T-cell-specific inactivation of IL-10, but not Foxp3(+) Treg-specific IL-10 ablation alone, resulted in elevated IFN-γ production by T cells associated with a significant decrease in viral loads in salivary glands. Thus, our data illustrate a crucial role for CD4(+)Foxp3(+) nTregs as well as IL-10-producing CD4(+)Foxp3(-) iTregs in the regulation of appropriate T-cell responses and viral clearance during mCMV infection.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25070242     DOI: 10.1038/icb.2014.62

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  22 in total

1.  Control of body temperature and immune function in patients undergoing open surgery for gastric cancer.

Authors:  Li Shao; Nannan Pang; Ping Yan; Fengju Jia; Qi Sun; Wenjuan Ma; Yi Yang
Journal:  Bosn J Basic Med Sci       Date:  2018-08-01       Impact factor: 3.363

Review 2.  Heterogeneity and Stability in Foxp3+ Regulatory T Cells.

Authors:  Booki Min
Journal:  J Interferon Cytokine Res       Date:  2017-07-11       Impact factor: 2.607

3.  Type I interferon signaling enhances CD8+ T cell effector function and differentiation during murine gammaherpesvirus 68 infection.

Authors:  Ryan N Jennings; Jason M Grayson; Erik S Barton
Journal:  J Virol       Date:  2014-09-24       Impact factor: 5.103

4.  Reconstitution and clinical significance of T cell subsets in the early stage after related HLA-mismatched peripheral blood hematopoietic SCT without T-cell depletion in vitro.

Authors:  Nannan Pang; Xianlin Duan; Ming Jiang; Jianhua Qu; Hailong Yuan; Jianli Xu; Haizhou Cao; Gang Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

5.  Peripheral blood Th9 cells reconstitution and its relationship with acute graft-versus-host disease after matched-sibling peripheral blood hematopoietic stem cell transplantation.

Authors:  Nannan Pang; Jianli Xu; Jianhua Qu; Xianlin Duan; Hailong Yuan; Gang Chen; Ming Jiang; Jianbing Ding
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

6.  Primate neural retina upregulates IL-6 and IL-10 in response to a herpes simplex vector suggesting the presence of a pro-/anti-inflammatory axis.

Authors:  Monica M Sauter; Curtis R Brandt
Journal:  Exp Eye Res       Date:  2016-05-08       Impact factor: 3.467

7.  Exploitation of Interleukin-10 (IL-10) Signaling Pathways: Alternate Roles of Viral and Cellular IL-10 in Rhesus Cytomegalovirus Infection.

Authors:  Meghan K Eberhardt; Ashlesha Deshpande; Joseph Fike; Rebecca Short; Kimberli A Schmidt; Shelley A Blozis; Mark R Walter; Peter A Barry
Journal:  J Virol       Date:  2016-10-14       Impact factor: 5.103

Review 8.  The Basis and Advances in Clinical Application of Cytomegalovirus-Specific Cytotoxic T Cell Immunotherapy for Glioblastoma Multiforme.

Authors:  Amin Daei Sorkhabi; Aila Sarkesh; Hossein Saeedi; Faroogh Marofi; Mahnaz Ghaebi; Nicola Silvestris; Behzad Baradaran; Oronzo Brunetti
Journal:  Front Oncol       Date:  2022-04-19       Impact factor: 5.738

9.  Mouse cytomegalovirus infection overrules T regulatory cell suppression on natural killer cells.

Authors:  Marc Lindenberg; Gulhas Solmaz; Franz Puttur; Tim Sparwasser
Journal:  Virol J       Date:  2014-08-09       Impact factor: 4.099

Review 10.  Combination of nanoparticle-based therapeutic vaccination and transient ablation of regulatory T cells enhances anti-viral immunity during chronic retroviral infection.

Authors:  Torben Knuschke; Olga Rotan; Wibke Bayer; Viktoriya Sokolova; Wiebke Hansen; Tim Sparwasser; Ulf Dittmer; Matthias Epple; Jan Buer; Astrid M Westendorf
Journal:  Retrovirology       Date:  2016-04-14       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.